Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Pacing Clin Electrophysiol. 2021 May;44(5):856-864. doi: 10.1111/pace.14226. Epub 2021 Apr 16.
Specific details about cardiovascular complications, especially arrhythmias, related to the coronavirus disease of 2019 (COVID-19) are not well described.
We sought to evaluate the incidence and predictive factors of cardiovascular complications and new-onset arrhythmias in Black and White hospitalized COVID-19 patients and determine the impact of new-onset arrhythmia on outcomes.
We collected and analyzed baseline demographic and clinical data from COVID-19 patients hospitalized at the Tulane Medical Center in New Orleans, Louisiana, between March 1 and May 1, 2020.
Among 310 hospitalized COVID-19 patients, the mean age was 61.4 ± 16.5 years, with 58,7% females, and 67% Black patients. Black patients were more likely to be younger, have diabetes and obesity. The incidence of cardiac complications was 20%, with 9% of patients having new-onset arrhythmia. There was no significant difference in cardiovascular outcomes between Black and White patients. A multivariate analysis determined age ≥60 years to be a predictor of new-onset arrhythmia (OR = 7.36, 95% CI [1.95;27.76], p = .003). D-dimer levels positively correlated with cardiac and new-onset arrhythmic event. New onset atrial arrhythmias predicted in-hospital mortality (OR = 2.99 95% CI [1.35;6.63], p = .007), a longer intensive care unit length of stay (mean of 6.14 days, 95% CI [2.51;9.77], p = .001) and mechanical ventilation duration(mean of 9.08 days, 95% CI [3.75;14.40], p = .001).
Our results indicate that new onset atrial arrhythmias are commonly encountered in COVID-19 patients and can predict in-hospital mortality. Early elevation in D-dimer in COVID-19 patients is a significant predictor of new onset arrhythmias. Our finding suggest continuous rhythm monitoring should be adopted in this patient population during hospitalization to better risk stratify hospitalized patients and prompt earlier intervention.
关于 2019 年冠状病毒病(COVID-19)相关心血管并发症,尤其是心律失常的具体细节描述得并不充分。
我们旨在评估黑人和白人住院 COVID-19 患者中心血管并发症和新发心律失常的发生率和预测因素,并确定新发心律失常对结局的影响。
我们收集并分析了 2020 年 3 月 1 日至 5 月 1 日期间在路易斯安那州新奥尔良市杜兰医疗中心住院的 COVID-19 患者的基线人口统计学和临床数据。
在 310 例住院 COVID-19 患者中,平均年龄为 61.4±16.5 岁,女性占 58.7%,黑人占 67%。黑人患者更年轻,更易患有糖尿病和肥胖症。心脏并发症的发生率为 20%,其中 9%的患者出现新发心律失常。黑人患者和白人患者的心血管结局无显著差异。多变量分析确定年龄≥60 岁是新发心律失常的预测因素(OR=7.36,95%CI [1.95;27.76],p=0.003)。D-二聚体水平与心脏和新发心律失常事件呈正相关。新发房性心律失常预测住院死亡率(OR=2.99,95%CI [1.35;6.63],p=0.007)、入住重症监护病房时间延长(平均 6.14 天,95%CI [2.51;9.77],p=0.001)和机械通气时间延长(平均 9.08 天,95%CI [3.75;14.40],p=0.001)。
我们的研究结果表明,新发房性心律失常在 COVID-19 患者中很常见,并可预测住院死亡率。COVID-19 患者中 D-二聚体的早期升高是新发心律失常的显著预测因子。我们的发现提示在住院期间应在这一患者人群中采用连续节律监测,以更好地对住院患者进行风险分层,并促使更早地进行干预。